Publication | Closed Access

Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy

ThrombosisMetabolic SyndromeVascular DiseaseLipid DisorderCardiovascular DiseasePcsk-9 InhibitorsPharmacologyHyperlipidemiaVascular BiologyLipid Lowering TherapyMedicineEndothelial Function ImprovementAtherosclerosisDyslipidemia